arrow
D

Daniel Blázquez-Gamero

catholic university of the sacred heart
H指数:30
被引数:8,383

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Urinary Cytomegalovirus Load at Birth as a Predictor of Sequelae in Congenital Cytomegalovirus Infection

新生儿尿液中巨细胞病毒载量作为先天性巨细胞病毒感染后遗症的预测因子

2026-01-011
PRE
Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth

Buonsenso, D.; Pedrero-Tomé, R.; Raimondi, F.; Salomé, S.; Papaevangelou, V.; Syridou, G.; Ríos-Barnés, M.; Fortuny, C.; Villaverde, S.; de Vergas, J.; 等. 先天性巨细胞病毒感染婴儿出生时听力评估正常者晚期听力损失预后因素. Pediatr. Infect. Dis. J. 2026, 45, 1–10. [Google Scholar] [CrossRef] [PubMed]

2026-01-013
PRE
Severe Neutropenia in Infants With Congenital Cytomegalovirus on Antiviral Therapy
2025-11-010
PRE
Multi-view deep learning framework for the detection of chest X-rays compatible with pediatric pulmonary tuberculosis

多视图深度学习框架,用于检测与儿科肺结核兼容的胸部X光片

2025-10-270
OAAI
Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis

15个欧洲国家在取消针对SARS-CoV-2的非药物干预措施后,儿科侵袭性A族链球菌感染及其与病毒感染的关联:一项中断时间序列分析

2025-10-180
OAAI
SHARP INCREASE IN THE INCIDENCE AND SEVERITY OF INVASIVE STREPTOCOCCUS PYOGENES INFECTIONS IN CHILDREN AFTER THE COVID-19 PANDEMIC (2019-2023): A NATIONWIDE MULTICENTER STUDY

COVID-19大流行后(2019-2023年)儿童侵袭性化脓性链球菌感染发病率和严重程度的显著增加:一项全国多中心研究

2025-07-160
OAAI
Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)

先天性及产后结核病患儿的临床表现、诊断及预后:Paediatric Tuberculosis Network European Trials Group (ptbnet) 多中心队列研究

2025-06-010
PRE
T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)
2024-09-014
PRE
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI) ( vol 40, 100892 , 2024)
2024-07-010
OA
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)
2024-05-0121
OAAI
Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
2024-04-031
PRE
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial

复制缺陷型人巨细胞病毒疫苗V160在巨细胞病毒阴性女性中的安全性,有效性和免疫原性: 一项双盲,随机,安慰剂对照,2b期试验

2023-12-0113
PRE
Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study)
2023-08-101
OA
Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain
2023-05-0414
OA
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
THORAX
IF7.7
2022-09-016
PRE
Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study
2021-11-2719
PRE